Alimera Sciences Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ALIM updated stock price target summary. Alimera Sciences Stock Price Forecast, ALIM stock price prediction. The best long-term & short-term Alimera Sciences share price prognosis for 2020, 2021, Stock Price Forecast for ALIM: Alimera Sciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks Price Target After Its Latest Report. As you might know, Alimera Sciences, Inc. ( NASDAQ:ALIM) recently reported its yearly numbers. Sales of US$54m came in After retracing 61.8% of this move, ALIM broke out of its' narrow channel flag with decent volume. If we see follow through ALIMs' first target is 8.29. 1. symbol, last, chg, %chg. PLXProtalix Biotherapeutics Inc, 2.17, -0.02, -0.91%. APENApollo Endosurgery Inc, 2.24, +0.31, +16.08%. ADMSAdamas View today's stock price, news and analysis for Alimera Sciences Inc. (ALIM). Barron's also provides information on historical stock ratings, target prices,
Alimera (ALIM) Gets a Buy Rating from H.C. Wainwright ...
Alimera Sciences, Inc. Common Stock (ALIM) Analyst ... Based on analysts offering 12 month price targets for ALIM in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your ALIM Price Target | Alimera Stock Forecast & Ratings See Alimera price target based on 2 analysts offering 12 month price targets for Alimera in the last 3 months. The average price target is $19.50 with a high forecast of $24.00 and a low forecast of $15.00. The average price target represents a 413.16% increase from the last price of $3.80.
Find the latest Alimera Sciences, Inc. (ALIM) stock quote, history, news and other vital information to help you with your stock trading and investing.
Alimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by ... Alimera Sciences (NASDAQ:ALIM)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued to investors on Tuesday, AnalystRatings.com reports. They presently have a $15.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 127.96% from the company’s previous Analyst Ratings for Alimera Sciences (ALIM)
Stock analysis for Alimera Sciences Inc (ALIM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Alimera (ALIM – Research Report) today and set a price target of $15.00. The company’s shares closed last Monday at $6.58. According to TipRanks.com, Chen is a 5-star analyst with an average return of 18.8% and a 51.0% success rate. Chen covers the Healthcare sector, focusing on Alimera Sciences (NASDAQ:ALIM) Stock Rating Reaffirmed by ... HC Wainwright reiterated their buy rating on shares of Alimera Sciences (NASDAQ:ALIM) in a research report sent to investors on Tuesday morning, AnalystRatings.com reports. They currently have a $15.00 target price on the biopharmaceutical company’s stock. ALIM has been the topic of a number of other research reports. Zacks Investment Research lowered shares of Alimera […] ALIM stock: buy or sell? - Alimera Sciences ALIM stock historical price chart. ALIM stock reached 52-week highs on December at $9.98, and all-time highs 2010-11-24 with a price of 12.7. ALIM stock price target How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms Alimera Sciences (NASDAQ:ALIM) Ratings | Benzinga Jan 01, 2010 · Alimera Sciences, Inc. (NASDAQ: ALIM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers
Alimera Sciences Inc. Stock Price (ALIM) | Barron's
Alimera Sciences Inc (NASDAQ:ALIM) price target set to $3 ... Nov 07, 2018 · Today, HC Wainwright set its price target on Alimera Sciences Inc (NASDAQ:ALIM) to $3.00 per share. There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. Alimera Sciences, Inc. (ALIM) Stock Price, Quote, History ... Alimera Sciences Appoints Steven T. Gill to the Newly Created Position of Vice President, Thought Leader Engagement. Alimera Sciences, Inc. (ALIM), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it has appointed Steven T. Gill as Vice President, Thought Leader Engagement. NASDAQ:ALIM Alimera Sciences, Inc. Stock Analysis ...
ALIM - Alimera Sciences, Inc. Summary, Stock ... - Benzinga Jan 01, 2010 · Alimera Sciences, Inc. (NASDAQ: ALIM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers Alimera Sciences Inc : ALIM Stock Price Quote at Ally Invest